SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-005753
Filing Date
2016-05-10
Accepted
2016-05-10 09:27:44
Documents
81
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arlz-20160331x10q.htm 10-Q 1338797
2 EX-10.1 arlz-20160331ex101794d21.htm EX-10.1 665196
3 EX-10.2 arlz-20160331ex10218d5c0.htm EX-10.2 72926
4 EX-31.1 arlz-20160331ex311153c22.htm EX-31.1 15221
5 EX-31.2 arlz-20160331ex3120ed00c.htm EX-31.2 19135
6 EX-32.1 arlz-20160331ex321575eee.htm EX-32.1 11014
7 EX-32.2 arlz-20160331ex322d09142.htm EX-32.2 11077
  Complete submission text file 0001558370-16-005753.txt   7592408

Data Files

Seq Description Document Type Size
8 EX-101.INS arlz-20160331.xml EX-101.INS 1490987
9 EX-101.SCH arlz-20160331.xsd EX-101.SCH 56407
10 EX-101.CAL arlz-20160331_cal.xml EX-101.CAL 66128
11 EX-101.DEF arlz-20160331_def.xml EX-101.DEF 226622
12 EX-101.LAB arlz-20160331_lab.xml EX-101.LAB 531148
13 EX-101.PRE arlz-20160331_pre.xml EX-101.PRE 408893
Mailing Address 1561 STEELES AVENUE EAST MILTON A6 L9T1Y1
Business Address 1561 STEELES AVENUE EAST MILTON A6 L9T1Y1 905-876-1118
Aralez Pharmaceuticals Inc. (Filer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37691 | Film No.: 161633945
SIC: 2834 Pharmaceutical Preparations